Tag - NEO

Developments

Adaptive partners with NeoGenomics to advance blood cancer monitoring

Adaptive Biotechnologies (NASDAQ:ADPT) and NeoGenomics (NASDAQ:NEO) have announced a multi-year exclusive collaboration aimed at advancing minimal residual disease (MRD) monitoring options for patients with select blood...

January 14, 2025

Markets

BTIG ups NeoGenomics to buy; PT $11

BTIG upgraded NeoGenomics (NASDAQ:NEO) to “buy” from “neutral” with a price target of $11, saying that with a cleaner slate, it expects the shares to outperform. The stock closed at $8.49 on April 13. Analyst Dr. Sean...

April 16, 2018

Tag - NEO

Adaptive partners with NeoGenomics to advance blood cancer monitoring

BTIG ups NeoGenomics to buy; PT $11

Subscribe